Citi and Wells Fargo Deliver Mixed Signals as US Bank Earnings Begin
Citigroup’s revenue-driven earnings beat contrasts with Wells Fargo’s weaker net interest income and revenue as Q3 results get underway.
UnitedHealth Raises 2026 Earnings Outlook Despite Elevated Medical Costs
UnitedHealth beat third-quarter estimates and raised its 2026 adjusted earnings outlook, offering a closely watched signal on managed-care r…
UnitedHealth Raises 2026 Profit Outlook, but Medical Costs Keep the Bull Case on Notice
UnitedHealth beat Q3 estimates and raised its 2026 adjusted earnings outlook, but elevated medical costs remain the central investor concern…
PepsiCo Stock Rallies After Guidance Cut: Can the Turnaround Outweigh the Earnings Pressure?
PepsiCo shares rallied despite a profit-guidance cut, as improving sales growth and demand investments offered investors evidence of a possi…
Accenture Stock Jumps 17.3% After Q4 Earnings Beat: What the Move Signals for Enterprise Tech Spending
Accenture’s 17.3% post-earnings jump puts enterprise technology and AI spending expectations in focus, though the available source offers no…
Micron Earnings Take Center Stage as Options Traders Position for a Potential Surprise
Micron’s after-the-bell report will test bullish options positioning and offer a read on sentiment across semiconductor and memory-chip stoc…
Micron Earnings Put AI Memory Demand and Chip-Stock Momentum to the Test
Micron’s after-the-bell report will test AI memory demand, options-market conviction and whether chip stocks can extend their recent momentu…
Zymeworks Updates 2026 Guidance After Finalizing Theravance Biopharma Deal Terms
Zymeworks’ updated 2026 guidance may give investors clearer visibility into cash flow and valuation after finalizing Theravance transaction …
Micron Stock Gains 1.4% Ahead of Next Week’s Earnings Report
Micron’s 1.4% pre-earnings gain puts the memory-chip cycle and AI semiconductor demand in focus ahead of next week’s report.
Macy's Q2 Success Signals Turnaround as Full-Year Guidance is Raised
Macy's beats Q2 earnings expectations, raising full-year guidance and signaling confidence in its turnaround.
Macy's Strong Q2 Results Signal Retail Resilience Amid Economic Challenges
Macy's Q2 earnings beat expectations and raised full-year guidance, showcasing resilience in retail.
Eli Lilly's Strategic Acquisition of Merida Biosciences: What Investors Need to Know
Eli Lilly's $2.875 billion acquisition of Merida Biosciences signals a strong M&A appetite in the pharmaceutical sector.